Profile | GDS5420 / 212634_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 307.46 | 59 |
GSM1296119 | B_lesional_pre-dose | 533.87 | 69 |
GSM1296076 | C_lesional_pre-dose | 552.3 | 70 |
GSM1296092 | D_lesional_pre-dose | 445.98 | 66 |
GSM1296103 | E_lesional_pre-dose | 352.65 | 62 |
GSM1296078 | F_lesional_pre-dose | 538.29 | 70 |
GSM1296107 | G_lesional_pre-dose | 744.26 | 75 |
GSM1296109 | H_lesional_pre-dose | 529.14 | 68 |
GSM1296080 | I_lesional_pre-dose | 245.42 | 56 |
GSM1296090 | J_lesional_pre-dose | 477.29 | 67 |
GSM1296074 | K_lesional_pre-dose | 554.7 | 70 |
GSM1296111 | L_lesional_pre-dose | 866.94 | 77 |
GSM1296099 | M_lesional_pre-dose | 352.62 | 61 |
GSM1296086 | O_lesional_pre-dose | 428.26 | 66 |
GSM1296117 | P_lesional_pre-dose | 733.75 | 74 |
GSM1296113 | Q_lesional_pre-dose | 738.1 | 74 |
GSM1296096 | R_lesional_pre-dose | 412.8 | 64 |
GSM1296105 | S_lesional_pre-dose | 318.53 | 59 |
GSM1296098 | T_lesional_pre-dose | 234.68 | 55 |
GSM1296101 | U_lesional_pre-dose | 309.83 | 59 |
GSM1296121 | V_lesional_pre-dose | 627.13 | 72 |
GSM1296088 | W_lesional_pre-dose | 373.09 | 63 |
GSM1296082 | X_lesional_pre-dose | 562.32 | 70 |
GSM1296115 | Y_lesional_pre-dose | 927.18 | 78 |
GSM1296084 | Z_lesional_pre-dose | 349.7 | 62 |
GSM1296072 | B_lesional_day8 | 362.37 | 62 |
GSM1296069 | L_lesional_day8 | 865.6 | 77 |
GSM1296071 | P_lesional_day8 | 578.85 | 70 |
GSM1296070 | Y_lesional_day8 | 604.46 | 71 |
GSM1296073 | V_lesional_day8 | 516.97 | 69 |
GSM1296034 | A_lesional_day15 | 214.35 | 52 |
GSM1296041 | G_lesional_day15 | 863.03 | 77 |
GSM1296035 | R_lesional_day15 | 284.35 | 58 |
GSM1296038 | U_lesional_day15 | 308.05 | 59 |
GSM1296047 | B_lesional_day15 | 465.05 | 66 |
GSM1296039 | E_lesional_day15 | 385.42 | 64 |
GSM1296042 | H_lesional_day15 | 686.74 | 73 |
GSM1296043 | L_lesional_day15 | 629.18 | 71 |
GSM1296037 | M_lesional_day15 | 235.81 | 54 |
GSM1296046 | P_lesional_day15 | 819.46 | 76 |
GSM1296044 | Q_lesional_day15 | 558.85 | 69 |
GSM1296045 | Y_lesional_day15 | 768.49 | 75 |
GSM1296025 | C_lesional_day15 | 302.98 | 60 |
GSM1296033 | D_lesional_day15 | 302.71 | 59 |
GSM1296027 | I_lesional_day15 | 226.75 | 56 |
GSM1296032 | J_lesional_day15 | 350.33 | 61 |
GSM1296024 | K_lesional_day15 | 230.92 | 55 |
GSM1296031 | W_lesional_day15 | 372.5 | 62 |
GSM1296028 | X_lesional_day15 | 276.58 | 58 |
GSM1296029 | Z_lesional_day15 | 320.48 | 60 |
GSM1296026 | F_lesional_day15 | 310.73 | 60 |
GSM1296030 | O_lesional_day15 | 243.18 | 57 |
GSM1296040 | S_lesional_day15 | 377.62 | 62 |
GSM1296036 | T_lesional_day15 | 323.63 | 59 |
GSM1296048 | V_lesional_day15 | 499.38 | 68 |
GSM1296059 | A_lesional_day43 | 244.57 | 56 |
GSM1296066 | G_lesional_day43 | 808.91 | 76 |
GSM1296060 | R_lesional_day43 | 322.09 | 60 |
GSM1296063 | U_lesional_day43 | 451.77 | 66 |
GSM1296064 | E_lesional_day43 | 479.39 | 68 |
GSM1296067 | H_lesional_day43 | 533.51 | 68 |
GSM1296062 | M_lesional_day43 | 212.63 | 53 |
GSM1296068 | Q_lesional_day43 | 586.83 | 70 |
GSM1296050 | C_lesional_day43 | 452.77 | 66 |
GSM1296057 | D_lesional_day43 | 326.52 | 60 |
GSM1296052 | I_lesional_day43 | 255.85 | 57 |
GSM1296054 | J_lesional_day43 | 310.32 | 59 |
GSM1296049 | K_lesional_day43 | 296.22 | 59 |
GSM1296055 | W_lesional_day43 | 430.17 | 65 |
GSM1296053 | X_lesional_day43 | 327.24 | 60 |
GSM1296058 | Z_lesional_day43 | 141.92 | 48 |
GSM1296051 | F_lesional_day43 | 442.86 | 66 |
GSM1296056 | O_lesional_day43 | 242.63 | 56 |
GSM1296065 | S_lesional_day43 | 457.39 | 66 |
GSM1296061 | T_lesional_day43 | 252.29 | 56 |
GSM1296095 | A_non-lesional_pre-dose | 485.48 | 67 |
GSM1296120 | B_non-lesional_pre-dose | 404.38 | 64 |
GSM1296077 | C_non-lesional_pre-dose | 230.34 | 55 |
GSM1296093 | D_non-lesional_pre-dose | 421.77 | 64 |
GSM1296104 | E_non-lesional_pre-dose | 331.88 | 61 |
GSM1296079 | F_non-lesional_pre-dose | 348.81 | 62 |
GSM1296108 | G_non-lesional_pre-dose | 554 | 69 |
GSM1296110 | H_non-lesional_pre-dose | 627 | 71 |
GSM1296081 | I_non-lesional_pre-dose | 238.6 | 56 |
GSM1296091 | J_non-lesional_pre-dose | 417.8 | 65 |
GSM1296075 | K_non-lesional_pre-dose | 384.61 | 64 |
GSM1296112 | L_non-lesional_pre-dose | 606.48 | 71 |
GSM1296100 | M_non-lesional_pre-dose | 255.75 | 56 |
GSM1296087 | O_non-lesional_pre-dose | 238.29 | 57 |
GSM1296118 | P_non-lesional_pre-dose | 596.9 | 70 |
GSM1296114 | Q_non-lesional_pre-dose | 690.36 | 73 |
GSM1296097 | R_non-lesional_pre-dose | 390.25 | 63 |
GSM1296106 | S_non-lesional_pre-dose | 491.47 | 67 |
GSM1296102 | U_non-lesional_pre-dose | 321.52 | 59 |
GSM1296122 | V_non-lesional_pre-dose | 398.31 | 64 |
GSM1296089 | W_non-lesional_pre-dose | 317.44 | 59 |
GSM1296083 | X_non-lesional_pre-dose | 284.92 | 58 |
GSM1296116 | Y_non-lesional_pre-dose | 755.35 | 75 |
GSM1296085 | Z_non-lesional_pre-dose | 274.72 | 58 |